Name: Stroke 2018
Start: 2018-10-22
End: 2018-10-24
Location: Austria

Renowned Speakers

11 influential Speakers

We’ve invited 11 of the most influential Speakers from around the world to give inspirational talks and lead practical workshops.

Dr. Kalyan Sapkota MD

Asst. Prof. Department of Medicine, Bharatpur Hospital, Nepal

Dr. Zuhal Kadhim, MD

Resident Physician at Mount Sinai Health System USA

Dr. Thamali Dissanayake

Resident Neurologist, Sri Lanka

Mr. Omer Dursun

University School of Physical Therapy, Turkey

Dr. Richa Tripathi

Banaras Hindu University, U.P, India

Prof. Dr. Miroslav Pohanka

University of Defence, Czech Republic

Assoc Prof Dr. Esther Lim

Division of Research, College of Osteopathic Medicine USA

Mr. Ibrahim Bukenya

Stroke Foundation Uganda, Uganda

Conference Information

About Conference

Stroke 2018 has been planning and aiming to stimulate new techniques for treatment of neurodegenerative disorders and stroke that would be beneficial for the neurosurgery.

The conference will be organized around the theme ‘Novel Approaches & Developments in Neurodegenerative Disorders and Stroke’.

Pulsus Group

Pulsus Group is a medical journals publisher that publishes, promotes and disseminates the work of medical researchers in a manner that exemplifies the highest standards in research integrity. Pulsus group is in alliance with Germany and other medical research associations of international level. It publishes medical journals that emphasize on medical specialties like Integrative Medicine, Cardiology, Surgery and Reproductive Medicine. Pulsus group is an association with prominent academic and research societies like Germany Society of Plastic Surgeons, German Society for Aesthetic Plastic Surgery and Germany Society for Surgery of the Hand.

Pulsus Group is an international level publisher in scientific, technical, and medical journals established within the year 1984 with offices in Ontario and Canada, India has reaped Andrew John publishing and openaccessjournals.com to expand its Open Access publishing through its 50+ journals in association with 20+ International medical and scientific societies.

Target Audience

Directors/Managers/CEO’s
Presidents & Vice Presidents
Neurologists
Neurosurgeons
Neurology doctors
Scientists and professors
Neuro research scholars
Medical Colleges
Research faculty
Academic Scientists
Students
Diagnostic laboratory professionals
Business Entrepreneurs
Industry professionals
Brand Manufacturers/ Marketers of Consumer Products
Marketing, Advertising and Promotion Agency Executives

Why to attend?

10+ Keynote Speaker Session
50+ speaker faculty over 2 full days sharing Evidence Based Nursing practice
5+ Workshops
13 Interactive sessions
Mixture of Health care units and Academia Delegates
Networking.

Sessions and Tracks

Session 01: Neurodegenerative Disorders

Neurodegeneration is the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative diseases – including amyotrophic lateral sclerosis, Parkinson's, Alzheimer's, and Huntington's – occur as a result of neurodegenerative processes. Such diseases are incurable, resulting in progressive degeneration and/or death of neuron cells. Many neurodegenerative diseases are caused by genetic mutations, most of which are located in completely unrelated genes. Neurodegeneration can be found in many different levels of neuronal circuitry ranging from molecular to systemic.

SUB-TRACKS

Cause and Symptoms
Ischemic Stroke
Haemorrhagic Stroke
Transient Ischemic Stroke
Diagnosis and awareness on Stroke

Related conferences: International Conference on Brain Disorders and Dementia Care, September 21-22, 2018, Philadelphia, USA| International Conference on Neuroimmunology and Neurological Disorders, September 26-27, 2018, Montreal, Canada| World Summit on Neurology & Neuroscience, September 26-27, 2018, Montreal, Canada| World Summit on Alzheimer’s, Neurodegenerative Diseases and Therapeutics, August 31-Sept 01, 2018, Boston, USA| 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session 02: Pediatrics

Pediatrics is well known as the new modern medicine of the society that incorporates the therapeutic care of newborn children; kids; and young people. It is the cutting edge study in the public today that decreases the death rates of children and adolescents and furthermore controls the spreading of pediatric infectious diseases. The aim of pediatrics study is to promote healthy lifestyles for a long infection free life and to facilitate children and adolescent problems. It incorporates the essential medications required for the improvement of the children health.

SUB-TRACKS

Pediatric Care
Pediatric Infectious Diseases
Adolescent Problems
Pediatric Behavioural Investigations
Pediatric Injuries
Anxiety Disorders
Developmental Disorders
Child Psychiatry
Pediatric Allergy and ImmunologI

Related Conferences: Pediatrics Conference; Neonatology Conference and Geriatrics Conference October 26-27; 2018 Osaka; Japan; Pediatric Neurology Conference November 19-20; 2018 Lisbon; Portugal; International Pediatric Urology Conference and Pediatrics Nephrology Care Conference October 26-27; 2018 Montreal; Canada; Pediatrics Conferences February 02-04; 2018 Whistler; British Columbia; PPS Annual Conference April 08-11; 2018 Philippines; NPPS Scientific Meeting & Conference April 28-29; 2018 Hotel Monaco; Seattle; Pediatrics Meeting August 13-14; 2018 Tokyo; Japan; Canadian Pediatric Conference January 10-14; 2018 Hamilton; Ontario.

Session 03: Neonatology and Perinatology

Neonatology is a medical specialty that deals with premature or ill infants. Perinatology is concerned with the care of the fetus and complicated high-risk pregnancies. Neonatal Intensive Care Unit is the vital constituent of neonatology. The new-born infants who are experiencing low birth-weight; innate deformities; sepsis; pneumonic hypoplasis; birth asphyxias and rashness are dealt with in the NICUs. Neonatologists concentrate on the care of new-borns that require Intensive Care Unit (ICU) hospitalization as their organs are not fully developed it can prompt host issues that require expert interventions. The key role of pediatric perinatology incorporates dealing with the fetus and the complicated health conditions during an incubation period.

SUB-TRACKS

Neonatal Infections
Non-invasive Neonatology
Neonatal Resuscitation
Intensive Care Unit
Neonatal Nutrition
Neonatal-Perinatal Medicine
Neonatal Congenital Effects
Pneumonic Hypoplasis
Birth Asphyxias
Innate Deformities

Related Conferences: Annual World Neonatology Congress June 27-28; 2018 Vancouver; Canada; European Pediatrics Conference September 10-12; 2018 Copenhagen; Denmark; International Pediatrics Conference and Neonatology Conference August 13-15; 2018 Rome; Italy; International Pediatrics Conference and Child Health Conference April 25-26; 2018 Dubai; UAE; Pediatrics Congress and Adolescent Medicine Congress July 09-10; 2018 Sydney; Australia; Pediatrics Conference & Neonatology Conference June 25-26; 2018 Kuala Lumpur; Malaysia; Pediatric Conference and Neonatal Conference February 08-09; 2018 Dubai; UAE.

Session 04: Neurotherapy

Neurotherapy is the Kind of treatment for neurodegenerative disorders. The philosophy behind neurotherapy involves activating or deactivating to the organ(s), through pressure or massage on the nerve channels to stimulate or depress the blood, & other body fluids and the nerve currents. The therapy focuses at the cause not at the symptoms of the disease. This method has no side effects and no instruments get involved in this treatment.

Mentally retarded child, Paralysis, Joint Pain, Chronic constipation, tail bone pain, Depression, Vertigo, Piles, Obesity, Hypothyroid, Insomnia, Anal fistula, Cramps, Diabetes, Cervical spondylitis, Arthritis, Angina pectoris, Menses related problem, Tennis elbow, Swelling, hair falling, Tilt, Allergy, Gastric problem, Motor neuron disease. These are the diseases which is successfully treated by neurotherapy.

SUB-TRACKS

Ayurvedic treatment
Inhibition of Cholinesterase Activity
Computational Approaches
Unani Treatment
Homeopathy treatment

Related conferences: 5th International Conference on Parkinson’s disease & Movement Disorders, October 19-20, 2018 New York, USA | 3rd International Conference on Neuropsychiatry and Sleep Medicine, September 21-22, 2018, Philadelphia, Pennsylvania, USA | 23rd International Conference on Neurology and Neurosurgery, November 23-24, 2018 Rome, Italy | 8th International Conference on Brain Science, Cognition and Research, September 21-22, 2018 Philadelphia, Pennsylvania, USA

Session 05: Etyology of Stroke and Risk Factors

A stroke is developed when the blood supply to part of your brain is interrupted or blocked, depriving brain tissue of oxygen and nutrients. Within minutes, brain cells begin to die. A stroke may be caused by a blocked artery (ischemic stroke) or the leaking or bursting of a blood vessel . Many factors can increase your stroke risk.. Potentially treatable stroke risk factors include: Being overweight or obese, Physical inactivity, Heavy or binge drinking and cigarette smoking or exposure to second hand smoke, High cholesterol, and Diabetes.

SUB-TRACKS

Brain Neurosurgery
Spine Neurosurgery
Cerebrovascular Surgery
Advanced Operative Techniques in Neurosurgery
Traumatic Neurosurgery
Neurosurgical Care

Related conferences: 23^rd International Conference on Neurology and Neurosurgery September 23-25, 2018 Rome, Italy| 3^rd International Conference on Central Nervous System Disorders & Therapeutics October 02-03, 2017 Vienna, Austria| 9^th International Conference on Alzheimer’s Disease & Dementia October 16-18, 2017 Rome, Italy| 2^nd International Conference on Neurology and Brain Disorders scheduled on August 04-06, 2018 at Rome, Italy| European Stroke Conference, Stroke meeting, August 11-13, 2018 Athens, Greece

Session 06: Preventive Stroke Strategies

Many stroke prevention strategies are the same as strategies to prevent heart disease. In general, healthy lifestyle recommendations include: Controlling high blood pressure (hypertension), Lowering the amount of cholesterol and saturated fat in your diet, Quitting tobacco use, Controlling diabetes, Maintaining a healthy weight, Eating a diet rich in fruits and vegetables, Exercising regularly, Drinking alcohol in moderation, if at all, Treating obstructive sleep apnea, Avoiding illegal drugs.

SUB-TRACKS

Acute Management
Medication Treatment with Alteplase IV r-tPA
Mechanical Treatment to Physically Remove the Clot
Fibrinolytic Therapy
Cerebral Edema Control
Anticoagulation & Prophylaxis
Neuroprotective Agents

Related conferences: International Conference on Sleep Disorders and Medicine, September 21-22, 2018, Philadelphia, USA | 5th International Conference on Parkinson’s Disease & Movement Disorders, October 19-20, 2018, Boston, USA | 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy | 2nd World Heart Congress, August 14-16, 2018, Tokyo, Japan.

Session 07: Neonatal Congenital Effects

Structural abnormalities are the most common type of congenital defects that exists in an infant even before birth and is known as birth defect. Teratogen causes anomaly in infants and some disorders can be detected through prenatal screening. Most of the defects caused due to inheritance are mostly rare.

SUB-TRACKS

Congenital Disorders
Genetic Syndromes
Neonatal Jaundice
Teratogen

Session 08: Stroke and Mental Health

A stroke is an emergency of medical aspect that requires early treatment that indicates early action can minimize brain damage and potential complications. Person affected by stroke addresses cognition and/or behavioral problems that includes problems using languages, vision and perception problems and sudden bursts of emotions.

SUB-TRACKS

Stroke Types
Mental Health Care
Mental Health Counselling
Mental Illness & Treatment
Mental Health & Rehabilitation
Stress Management Programs
Assessment of Mental & Behavioral Disorders
Mental Health Nursing Practice
Mental health on Sports

Related conferences: 11th International Conference on Alzheimer’s Disease & Dementia, August 24-25, 2018, Vienna, Austria | 25th World Congress on Neurology & Neuroscience, September 18-19, 2018 Dublin, Ireland | 25th World Congress on Neurology and Neurodisorders, November 16-17, 2018 Melbourne, Australia | 4th Global Congress on Spine and Spinal Disorders, September 05-06, 2018 Auckland

Session 09: Dementia

Dementia is a syndrome characterized by cognitive or memory impairments that describes the symptoms of many conditions that affects the brain. The commonly seen conditions are Alzheimer’s and Parkinson’s disease. Symptoms seen at early stages are memory loss, personality changes, withdrawal and confusion.

SUB-TRACKS

Neurocognitive Disorders
Dementia with Lewy bodies
Mixed Dementia
Vascular Dementia
Frontotemporal Dementia
Need for awareness on dementia

Related conferences: 4^th International Conference on Neurological Disorders & Stroke September 19-20, 2018 Dubai, UAE | 3^rd International Conference on Neuro-Oncology and Brain Tumor October 19-20, 2018 Dubai, UAE | 25^thGlobal Meeting on Neurology & Neuroscience September 14-16 Dublin, Ireland | AAN Neurology 2018 Annual Meeting, August 21-27, 2018, Los Angeles, USA | Neuroscience 2017 November 11-15, Washington, DC

Session 10: Vascular and Brain Imaging

Vascular imaging is a key component in the brain stroke 2018 International Conference for comprehensive stroke diagnosis and cause based therapy. Siemens supports with the full spectrum of angiography systems available today. Siemens analysis tools reduce the information load by removing distracting visual input (e.g. skull base) in intra-arterial (X-ray), CT, MR, and US angiography. Consequently, it assists in focusing on vascular changes and interventional procedures such as clot removal, thrombolysis and stent implantation. Tools for imaging of brain function includes Magnetic resonance spectroscopy, Single photon emission computed tomography, Functional magnetic resonance imaging (fMRI), Magnetoencephalography (MEG).

SUBTRACKS

Computed Tomography Scan
Electroencephalogram
Magnetic Resonance Imaging
Electromyography
Positron Emission tomography
Spinal Tap
Neurosonography

Related conferences: International Conference on Neuroimmunology, Neurological disorders and Neurogenetics, September 26-27, 2018 Montreal, Canada| 7th World Summit on Heart, Stroke & Neurological Disorders, August 31-September 01, 2018, Massachusetts, USA| International Conference on Brain Injury and Neurological Disorders, September 10-12, 2018 Amsterdam, Netherlands| 2nd International Conference on Neurology & Neurophysiology, August 23-24, 2018 Rome, Italy

Session 11: Hemorrhagic Stroke

Hemorrhagic stroke involves bleeding within the brain, which damages nearby brain tissue and there are two types of hemorrhagic stroke: intracranial hemorrhage (ICH), which occurs with bleeding into the brain tissue and subarachnoid hemorrhage (SAH), which occurs with bleeding into the subarachnoid space beneath the arachnoid mater of the meninges. Causes of hemorrhagic stroke include Aneurysms, arteriovenous malformation (AVM), and Cerebral amyloid angiopathy.

SUB-TRACKS

Cognitive Behavioral Therapy (CBT)
Theories of Behavioral Science
Cross-cultural Psychology & Behavioral genetics
Behavioral Problems in Children & Adults
Critically evaluated Empirical research

Related conferences: 23^rd International Conference on Neurology and Neurosurgery August 23-25, 2018 Rome, Italy| 3^rd International Conference on Central Nervous System Disorders & Therapeutics October 02-03, 2017 Vienna, Austria| 9^th International Conference on Alzheimer’s Disease & Dementia October 16-18, 2017 Rome, Italy| 2^nd International Conference on Neurology and Brain Disorders scheduled on November 04-06, 2018 at Rome, Italy| European Stroke Conference, Stroke meeting, September 11-13, 2018 Athens, Greece

Session 12: Stroke Rehabilitation and Recovery

Stroke is one of the main leading causes of long term adult disability which is affecting approximately 795,000 people each year in the USA.

Someone who suffered a stroke can improve functions and sometimes remarkable recoveries by early recovery and rehabilitation.

The goal of a stroke rehabilitation program is to help you relearn skills which are lost when stroke affected part of your brain. Stroke rehabilitation can help to regain independence and improve the quality of life.

SUB-TRACKS

Stroke Risk Assessment Tool (SRAT)
The Cincinnati Prehospital Stroke Scale
The Los Angeles Prehospital Stroke Screen
The National Institutes of Health Stroke Scale (NIHSS)
Anticoagulant and Antiplatelet Agents
Blood Pressure Control
Manage exercise and diet

Session 13: Pediatrics: Stroke and Metabolic Disorders

Stroke is more common in boys than girls even after controlling for differences in frequency of causes trauma and these appears to be a predominance of stroke in black children. This difference remains true even after accounting for sickle cell disease patients with stroke and moreover seizures are common in both ischemic and hemorrhagic strokes. They occur in up to 50% of children with strokes are not restricted to any age group and are not limited to any specific seizure type. A stroke or cerebral vascular accident (CVA) in children is typically considered to be a rare event. The reported incidence of combined and hemorrhagic ischemic pediatric stroke ranges from 1.2 to 13 cases per 100,000 children under 18 years of age.

Non-contrast head computed tomography (CT) is sensitive for acute bleeding and should be obtained emergently to exclude a cause for hemorrhagic stroke. Despite increasingly advanced imaging techniques the adult literature suggests that a lumbar puncture is still needed to rule out a subarachnoid hemorrhage.

SUB-TRACKS

Mental Health
Neurogenetic and Neurometabolic disorders
Addictive Disorders
Neurotoxicity
Myasthenia Gravis & Related Disorders
Neurocognitive changes in AIDS

Related conferences: 4th Global Experts Meeting on Parkinson’s & Movement Disorders, August 14-15, 2018 Singapore| 3rd International Conference on Spine and Spinal Disorders, September 11-12, 2018 London, UK| 21st World Congress on Neurology and Therapeutics, March 15-17, 2018 London, UK| , International Stroke Conference 2018, October 24–26, 2018, Los Angeles, USA

Session 14: Pediatric Critical Care

Pediatric Critical Care is concerned with the diagnosis and management of life-threatening conditions that requires organ support and invasive monitoring. Critical care treatment raises issues that includes psychological health; pressure points; mobilisation and physiotherapy; and secondary infections. Critical care is provided to the children whose condition is potentially reversible and who have a good chance of surviving with intensive care support. A prime imperative for admission to an emergency unit is that the basic condition can be overcome. Convenient diagnosis and initiation of treatment are required in order to counteract unnecessary increases in patient morbidity and mortality.

SUB-TRACKS

Cardiovascular System
Central Nervous System
Endocrine System
Gastro-Intestinal Tract
Hematology
Renal System
Respiratory System

Related Conferences: Pediatrics Primary Care Conference September 03-04; 2018 Zurich; Switzerland; Pediatrics Health Conference August 06-07, 2018 Madrid; Spain; World Neurology Congress and Therapeutics Congress March 15-17; 2018 London, United Kingdom; Pediatric Nutrition Conference July 19-21; 2018 London; United Kingdom; Pediatrics Meeting and Child Health Meeting April 25-26; 2018 Dubai; UAE; ; Parkinson Disease Conference and Movement Disorder Conference October 05-09; 2018 Hong Kong; China; Pediatrics Congress and Adolescent Medicine Congress July 09-10; 2018 Sydney; Australia.

Session 15: Vascular Surgery and Neurosurgery

The Neurovascular surgery specializes in the management of complex central nervous system vascular disorders including arteriovenous malformations, aneurysms, cavernous angiomas and carotid and intracerebral stenosis. Surgery and vascular procedures can be used to prevent stroke to treat or to repair damaged blood vessels or malformations in and around the brain. Carotid endarterectomy is a surgical procedure in which a surgeon removes fatty deposits or plaque from the inside of one of the carotid arteries and this procedure is performed to prevent stroke.

SUB-TRACKS

Therapeutic targets & mechanism for treatment
Alzheimer’s disease symptoms
Rehabilitation Facilities
Skills & Techniques in Clinical training
Clinical Evaluation
Practices in Clinical training
Promoting Clinical Outcomes

Related conferences: 4^th International Conference on Neurological Disorders & Stroke November 19-20, 2018 Dubai, UAE | 3^rd International Conference on Neuro-Oncology and Brain Tumor September 19-20, 2018 Dubai, UAE | 25^thGlobal Meeting on Neurology & Neuroscience October 14-16 Dublin, Ireland | AAN Neurology 2018 Annual Meeting, September 21-27, 2018, Los Angeles, USA | Neuroscience 2017 November 11-15, Washington, DC

Session 16: Current Breakthrough in Stroke Research

The randomized clinical research study shows a dramatic improvement in restoring blood back to the brain in arteries. This study involved minimally invasive clot procedure known as stent thrombectomy and this standard clot procedure called as tissue plasminogen activator. In patients with more severe strokes, each trail shows the striking benefit of catheter-based clot removal to restore blood flow in brain arteries. This can be used to improve the treatment for heart attacks known as acute stroke therapy. There is another new treatment for the stroke shown to be very effective that and it will be used as a part of standard stroke care.

SUB-TRACKS

Stroke rehabilitation: Care and guidance
Migraine & Chronic Pain
Neuropsychiatric Conditions
Neuropathic infections
Neuropathic pain in women’s
Functional electrical stimulation
Spinocerebellar ataxia
Neuropathy and therapies
Spinal muscular atrophy
Advanced neuropathic therapies
Neuropathic pain and its therapeutics

Session 17: Clinical Trials & Case Reports

Clinical trials and case reports includes the involvement of larger groups of people confirming the effectiveness of a drug or treatment, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely. This track gives researchers knowledge about new technologies, clinical trials and new aspects.

SUB-TRACKS

Prevention trials
Case Reports on Stroke
Advances in genetic research
Case Reports on Neurodegenerative Disorders
History of present illness in affected patients
Case Reports on Neuro Oncology
Coping with caring
Vaccination by self-antigens
History of present illness in affected patients

Related conferences: 11th International Conference on Alzheimer’s Disease & Dementia, August 24-25, 2018, Vienna, Austria | 25th World Congress on Neurology & Neuroscience, September 18-19, 2018 Dublin, Ireland | 25th World Congress on Neurology and Neurodisorders, August 16-17, 2018 Melbourne, Australia | 4th Global Congress on Spine and Spinal Disorders, September 05-06, 2018 Auckland

Market Analysis

SCOPE AND IMPORTANCE

Globally the market for stroke disorder & treatments increasing rapidly. The major factor that derives the growth of stroke disorder & treatment is the increasing high blood pressure patients. Ischemic stroke is caused by a dysfunction in the supply of blood to the brain due to emboli, thrombus or atherosclerosis occurring in cerebral arteries. According to a World Health Organization (WHO) estimate, around 17 million people die every year due to cardiovascular diseases. The statistics of the Centres for Disease Control and Prevention suggest that about 87% of all strokes are ischemic strokes. Moreover, stroke leads to 1 out of every 20 deaths, costing around $34 billion to U.S. annually. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices.

The two major factors propelling the growth of the acute ischemic stroke diagnosis and treatment market are; large patient pools and a concerning rise in population at a higher risk of developing stroke in the near future. Rising incidence of diabetes along with heavy tobacco users and an increase in the ageing population are significant factors that determine the market growth.

New Product launches and collaborations are some of the key strategies adopted by leading industry players. In March, 2015, FDA approved WATCHMAN, a left atrial appendage closure device designed to prevent stroke in patients with atrial fibrillation. Silk Road Medical, Inc. has launched an Anti-Stroke Enroute Device, a transcarotid neuroprotection system, designed to access the common carotid artery through a minimally invasive technique. NeuroVive Pharmaceutical AB, entered into collaboration with BBB Therapeutics, for development of the NVP014 drug candidate used in the treatment of ischemic strokes.

COMPANIES

Abbott Laboratories
Medtronic plc
Boston Scientific Corporation
Cordis Corporation
Koninklijke Philips N.V
GE Healthcare
Siemens AG
Stryker Corporation
Genentech, Inc. and Merck & Co., Inc.

Acute Ischemic Stroke Diagnosis and Treatment Market By Type

Diagnostics
- Computed Tomography (CT)
- Magnetic resonance imaging (MRI)
- Carotid Ultrasound
- Cerebral Angiography
- Electrocardiography
- Echocardiography
Therapeutics
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive